Sometimes, in tragic circumstances, a lesson can be learned and applied in unexpected ways. That appears to be the case with a rare disease that...

We have recently discussed here how crowdfunding – donations from the general public in support of a cause, idea, or invention – has caught the...

It’s been two years in the making, but a digital portal now connects 10 Kansas City-area research organizations with one another and with the...

Connecting academic scientists to the global life science ecosystem Like everyone else, academic researchers are finding that funding sources are...

As we previously discussed, CRISPR-mania is sweeping the globe. (Okay, it might not be as big as Beatlemania, but more than a few life science...

It’s a sad story that everyone is familiar with: A patient takes one or more well-known cancer drugs, and they work – for a while. However, after...

Don’t doubt West Coast investor Parker Hinshaw’s dedication to his home state of Indiana. He and his wife, Jean Balgrosky, in 2012 founded San...

Over the course of this series so far we’ve looked at the role of the microbiome in two of the three major therapeutic areas targeted by drug...

Scientist Inc. is an online marketplace that connects researchers and companies, allowing them to outsource some of their lab processes by...

The vast majority of compounds that enter clinical trials fail to make it through. The result: few drugs, plenty of bills. The consensus in drug...